Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Chinese Patent Office
Express Scripts
US Army
Argus Health
McKinsey
Cerilliant
UBS
Teva

Generated: May 21, 2018

DrugPatentWatch Database Preview

Fougera Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for FOUGERA PHARMS, and when can generic versions of FOUGERA PHARMS drugs launch?

FOUGERA PHARMS has one hundred and twelve approved drugs.

There are four US patents protecting FOUGERA PHARMS drugs.

There are fifty-nine patent family members on FOUGERA PHARMS drugs in twenty-seven countries and thirty-two supplementary protection certificates in twelve countries.

Summary for Fougera Pharms
International Patents:59
US Patents:4
Tradenames:53
Ingredients:45
NDAs:112

Drugs and US Patents for Fougera Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms Inc VEREGEN sinecatechins OINTMENT;TOPICAL 021902-001 Oct 31, 2006 RX Yes Yes 7,858,662 ➤ Try a Free Trial Y ➤ Try a Free Trial
Fougera Pharms TYZINE tetrahydrozoline hydrochloride SOLUTION;NASAL 086576-002 Approved Prior to Jan 1, 1982 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Fougera Pharms TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 085692-001 Approved Prior to Jan 1, 1982 AT RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Fougera Pharms Inc VEREGEN sinecatechins OINTMENT;TOPICAL 021902-001 Oct 31, 2006 RX Yes Yes 9,770,406 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Fougera Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,852,002 ➤ Try a Free Trial
Fougera Pharms PANDEL hydrocortisone probutate CREAM;TOPICAL 020453-001 Feb 28, 1997 4,794,106 ➤ Try a Free Trial
Fougera Pharms ACLOVATE alclometasone dipropionate CREAM;TOPICAL 018707-001 Dec 14, 1982 4,124,707 ➤ Try a Free Trial
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,792,753 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for FOUGERA PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Lotion 0.05% ➤ Subscribe 2008-07-28
➤ Subscribe Topical Gel 3% ➤ Subscribe 2009-12-16

Non-Orange Book US Patents for Fougera Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,968,973 Method for treating hyperplasia ➤ Try a Free Trial
6,197,808 Methods for treating hyperplasia ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Fougera Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB15/042 United Kingdom ➤ Try a Free Trial PRODUCT NAME: DRY EXTRACT FROM CAMELLIA SINENSIS (L.) O.KUNTZE FOLIUM (GREEN TEA LEAVES) CORRESPONDING TO (-)-EPIGALLOCATECHIN GALLATE; REGISTERED: DE 73486.00.00 20090831; UK PL39972/0003 20150324
90030-4 Sweden ➤ Try a Free Trial PRODUCT NAME: TORRT EXTRAKT AV CAMELLIA SINENSIS (L.) O. KUNTZE, FOLIUM; NAT. REG. NO/DATE: 47136 20120405; FIRST REG.: DE 73486.00.00 20090831
C/GB99/003 United Kingdom ➤ Try a Free Trial PRODUCT NAME: IMIQUIMOD; REGISTERED: UK EU/1/98/080/001 19980918
0 5025-2012 Slovakia ➤ Try a Free Trial PRODUCT NAME: PURIFIKOVANY SUCHY EXTRAKT ZO ZELENEHO CAJU (CAMELLIA SINENSIS (L.) O. KUNTZE) A IZOPROPYLMYRISTAT; NAT. REGISTRATION NO/DATE: 46/0306/12-S 20120716; FIRST REGISTRATION: DE 73486.00.00 20090831
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Department of Justice
Queensland Health
Merck
McKinsey
McKesson
Covington
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.